Loxapine Inhalation Powder: A Review of its Use in the Acute Treatment of Agitation in Patients with Bipolar Disorder or Schizophrenia.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 479, doi. 10.1007/s40263-013-0075-9
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2013 AND VI 27 AND IP 6
Results: 8
1
2
The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 423, doi. 10.1007/s40263-013-0062-1
- By:
- Publication type:
- Article
3
Erratum to: The Role of Antipsychotics in the Management of Fibromyalgia.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 491, doi. 10.1007/s40263-013-0066-x
- By:
- Publication type:
- Article
4
The Long-Term Safety of Antiepileptic Drugs.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 435, doi. 10.1007/s40263-013-0063-0
- By:
- Publication type:
- Article
5
Publication Bias, with a Focus on Psychiatry: Causes and Solutions.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 457, doi. 10.1007/s40263-013-0067-9
- By:
- Publication type:
- Article
6
Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 411, doi. 10.1007/s40263-013-0064-z
- By:
- Publication type:
- Article
7
The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer's Disease Taking Cholinesterase Inhibitors.
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 469, doi. 10.1007/s40263-013-0077-7
- By:
- Publication type:
- Article
8
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
- Published in:
- CNS Drugs, 2013, v. 27, n. 6, p. 403, doi. 10.1007/s40263-013-0065-y
- By:
- Publication type:
- Article